Back to Archived Journals » Orphan Drugs: Research and Reviews » Volume 4 » default
Orphan Drugs: Research and Reviews ceased publishing in September 2018. All articles that have been published in Orphan Drugs: Research and Reviews will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Orphan Drugs: Research and Reviews
ISSN: 2230-6161
- View all (36)
- Volume 7, 2017 (4)
- Volume 6, 2016 (1)
- Volume 5, 2015 (12)
- Volume 4, 2014 (11)
- Volume 3, 2013 (3)
- Volume 2, 2012 (4)
- Volume 1, 2011 (1)
Archive: Volume 4, 2014
Optimal management of interstitial lung disease associated with dermatomyositis/polymyositis: lessons from the Japanese experience
Kurasawa K, Arai S
Orphan Drugs: Research and Reviews 2014, 4:93-107
Published Date: 21 November 2014
Orphan drugs in glioblastoma multiforme: a review
Lassen U, Mau-Sørensen M, Poulsen HS
Orphan Drugs: Research and Reviews 2014, 4:83-91
Published Date: 14 November 2014
New treatments in development for Pseudomonas aeruginosa infections in the lungs of individuals with cystic fibrosis
Akhand SS, Pettit RS, Gardner TE, Anderson GG
Orphan Drugs: Research and Reviews 2014, 4:71-81
Published Date: 24 October 2014
Orphan drugs in development for urea cycle disorders: current perspectives
Häberle J, McCandless SE
Orphan Drugs: Research and Reviews 2014, 4:63-70
Published Date: 30 September 2014
Angiogenesis inhibitors in gastric cancer
McCarthy T, O'Neil BH
Orphan Drugs: Research and Reviews 2014, 4:55-61
Published Date: 14 July 2014
An update on gene therapy for the treatment of lipoprotein lipase deficiency
Libby AE, Wang H
Orphan Drugs: Research and Reviews 2014, 4:47-54
Published Date: 15 May 2014
Access to cross-border health care services for patients with rare diseases in the European Union
Aagaard L, Kristensen K
Orphan Drugs: Research and Reviews 2014, 4:39-45
Published Date: 11 April 2014
Stiripentol for the treatment of Dravet syndrome
Chiron C
Orphan Drugs: Research and Reviews 2014, 4:29-38
Published Date: 2 April 2014
A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups
Dunkle M
Orphan Drugs: Research and Reviews 2014, 4:19-27
Published Date: 17 February 2014
Profile of aminopyridines for Lambert–Eaton myasthenic syndrome
Maddison P, Keogh MJ, Sedehizadeh S
Orphan Drugs: Research and Reviews 2014, 4:11-18
Published Date: 20 January 2014
Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations
Iskrov G, Stefanov R
Orphan Drugs: Research and Reviews 2014, 4:1-9
Published Date: 9 January 2014